G protein-gated inwardly rectifying K ؉ (Kir) channels are found in neurones, atrial myocytes, and endocrine cells and are involved in generating late inhibitory postsynaptic potentials, slowing the heart rate and inhibiting hormone release. They are activated by G proteincoupled receptors (GPCRs) via the inhibitory family of G protein, G i/o, in a membrane-delimited fashion by the direct binding of G␤␥ dimers to the channel complex. In this study we are concerned with the kinetics of deactivation of the cloned neuronal G protein-gated K ؉ channel, Kir3.1 ؉ 3.2A, after stimulation of a number of GPCRs. Termination of the channel activity on agonist removal is thought to solely depend on the intrinsic hydrolysis rate of the G protein ␣ subunit. In this study we present data that illustrate a more complex behavior. We hypothesize that there are two processes that account for channel deactivation: agonist unbinding from the GPCR and GTP hydrolysis by the G protein ␣ subunit. With some combinations of agonist͞GPCR, the rate of agonist unbinding is slow and rate-limiting, and deactivation kinetics are not modulated by regulators of G protein-signaling proteins. In another group, channel deactivation is generally faster and limited by the hydrolysis rate of the G protein ␣ subunit. G protein isoform and interaction with G protein-signaling proteins play a significant role with this group of GPCRs.
M
embers of the family of inwardly rectifying K ϩ (Kir) channels gated by G proteins were first identified in atrial myocytes, where they are activated through stimulation of M 2 muscarinic receptors by acetylcholine (1) . Physiologically, activation of this current is partly responsible for slowing of the heart rate in response to vagal-nerve stimulation (2, 3) . It is now known that channel activation is membrane-delimited (4), mimicked by nonhydrolyzable GTP analogues (5) , and sensitive to pertussis toxin (PTx), implicating the inhibitory family of G proteins (G i/o ) (6) . Channel activation occurs because of direct binding of G␤␥ dimers, released from G i/o ␣-containing heterotrimers, to domains on the channel (7) (8) (9) . G protein-gated Kir channels are also expressed in many central neurones, where they can be activated by a large variety of neurotransmitters acting at G i/o -coupled receptors (10) including ␥-aminobutyric acid (GABA) at the GABA type B (GABA B ) receptor complex and adenosine at A 1 receptors, and they mediate postsynaptic inhibitory events (9, 11, 12) . The molecular counterparts of these currents have now been identified by cloning techniques (13) (14) (15) (16) : the channel is a heterotetramer of members of the Kir3.0 family of K ϩ channels. Coexpression of Kir3.1 with Kir3.2 or Kir3.4 in heterologous expression systems results in currents that show many of the basic characteristics of the native channels in neurones and atria, respectively.
The kinetic behavior of these channels after agonist application and withdrawal has been a subject of intense investigation. To date, these issues have largely been addressed by using the cloned atrial channel, Kir3.1 ϩ 3.4, and the muscarinic M 2 receptor expressed in Xenopus laevis oocytes (17, 18) . In particular, a number of studies have sought to explain why these channels when expressed in X. laevis oocytes deactivate more slowly than the native atrial current following stimulation of M 2 receptors. The identification of the family of G protein-signaling (RGS) proteins can account, in part, for this discrepancy (17, 18) . RGS proteins interact with G i/o and G q/11 ␣ subunits to increase the intrinsic GTPase rate of the G␣ subunit (19) (20) (21) (22) (23) . Overexpression of RGS4, for example, accelerates the channel-deactivation kinetics and changes other kinetic parameters such that the measured time constants are more consistent with those occurring after stimulation of native channels in atrial cells (17, 18, (24) (25) (26) . Because this family of channels can be activated by a wide variety of G i/o -coupled G protein-coupled receptors (GPCRs) in heterologous and native conditions, it is important to establish how general such processes are, and it is these issues that we address in the current study.
Materials and Methods
Molecular Biology, Cell Culture, and Transfection. We generated and used a series of PTx-resistant G i/o mutant ␣ subunits and cyan fluorescent protein (CFP)-tagged PTx-resistant G i/o ␣ subunits as described (27, 28) . In addition, we also made RGS-insensitive G i ␣ 1 and G o ␣ A where the PTx-resistant G i ␣ 1 C351G and G o ␣ A C351G were mutated further to G183S and G184S, respectively (29) . Mutations were introduced by using the QuikChange kit (Stratagene) and confirmed by using automated DNA sequencing (Cytomyx, Cambridge, U.K.). GABA-B 1b and GABA-B 2 were expressed in the dual-promoter vector pBudCE4.1 (Invitrogen) following the use of standard molecular cloning techniques to excise the clones from the previous vector, pcDNA3.1͞neo͞(ϩ). The excised GABA-B 1b (PmeI͞XhoI) and GABA-B 2 (KpnI͞XhoI) then were introduced into the two polylinkers in pBudCE4.1 (GABA-B 1b , ScaI͞SalI sites; GABA-B 2 , KpnI͞XhoI sites).
Cell-culture methods and the generation of stable cell lines were as described (30, 31) . In addition to the stable lines wae have described previously [Kir3.1ϩ3.2A channel plus either the A 1 adenosine receptor (HKIR3.1͞3.2͞A1) or the D 2S dopaminergic receptor (HKIR3.1͞3.2͞D2)], we used a further three-dualreceptor ϩ channel stable lines that were denoted as ␣ 2A adrenergic receptor (HKIR3.1͞3.2͞␣2), GABA-B 1b/2 receptor (HKIR3.1͞3.2͞ GGB), and M 4 -muscarinic receptor (HKIR3.1͞3.2͞M4). Monoclonal cell lines were established by picking single colonies of cells after transfection and growth under selective pressure. For all of the dual-receptor and channel-expressing lines we used a dual-selection strategy with 727 g͞ml G418 and 364 g͞ml Zeocin (Invitrogen). Transiently transfected cells suitable for patch-clamping were identified by epifluorescence from cotransfection of 100 ng of the This paper was submitted directly (Track II) to the PNAS office.
enhanced variant of the GFP (pEGFP-N1; CLONTECH). Data were obtained from at least two independent transfections.
Electrophysiology. Whole-cell membrane currents were recorded by using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA). Patch pipettes were pulled from filamented borosilicate glass (Clark Electromedical Instruments, Pangbourne, U.K.) and had a resistance of 1.5-2.5 M⍀ when filled with pipette solution (see below). Before filling, tips of patch pipettes were coated with a Parafilm͞mineral oil suspension. Data were acquired and analyzed by using a Digidata 1200B interface (Axon Instruments) and PCLAMP 6.0 software (Axon Instruments). Cell capacitance was Ϸ15 pF, and series resistance (Ͻ10 M⍀) was at least 75% compensated by using the amplifier circuitry. Recordings of membrane current were commenced after an equilibration period of Ϸ5 min. Immediately after patch rupture a current-voltage relationship was performed to establish that currents were inwardly rectifying. Thereafter cells were voltage-clamped at Ϫ60 mV, and agonistinduced currents were measured at this potential. For currentvoltage relationships, records were filtered at 1 kHz and digitized at 5 kHz. For continual data acquisition where cells were voltageclamped at Ϫ60 mV, records were digitized at 100 Hz. Drugs were applied by using a ''sewer-pipe'' system (Rapid Solution Changer RSC-160; Biologic, Grenoble, France) whereby an array of perfusion capillaries was placed in the bath Ϸ40 m from the recorded cell. This system allowed rapid solution switching between capillary tubes and localized application of drugs due to the laminar flow over the studied cell from the pipes as described (32) . After agonist application, current activated with an initial delay (''lag'') followed by a rapid rise to peak amplitude (''time to peak''). In some figures we illustrate this as lag ϩ time to peak. During continued agonist application currents exhibited desensitization. However, in this study we particularly focused on the deactivation kinetics, the decay of current back to baseline after removal of agonist. This declining phase was fitted to a single exponential decay function, A⅐exp(Ϫt͞) ϩ C (where A is the current amplitude at the start of the fit, t is time, is the deactivation time constant, and C is the steady-state asymptote, using a Simplex iterative procedure where the sum of squared errors was minimized). F tests indicated that the deactivation phase was best fitted by a single exponential time constant. In some recordings of HKIR3.1͞3.2͞A1 cells, we observed a transient increase in current after removal of agonist. In these cells channel-deactivation rates were measured during the declining phase of the current after the peak of current reactivation.
For each cell we assessed whether there were any flow artifacts resulting from the pressure of drug application. We did this by applying bath solution from one of the sewer pipes and recording any flow-induced currents. If any such current was observed, then the position of the perfusion head was moved to minimize it. Furthermore, to control for variations in positioning of the sewerpipe system relative to the cell, we calibrated this system by using the kinetics of channel block by barium. The cell was positioned in the center of the field by using cross hairs in the microscope eyepieces. Barium (1 mM) was applied to the cell in the presence of agonist when the agonist-induced current had reached a plateau phase. Block of the current occurred with an initial delay before reaching equilibrium. It was assumed that this lag reflected the intrinsic delivery time to the cell. A barium calibration was performed before the start of experiments to ascertain correct positioning of the sewer pipe and was repeated on several cells during each recording session. In general the results were highly repro- ducible (the lag time for barium block was 237.3 Ϯ 11.68 ms; n ϭ 73).
Membrane currents were measured at Ϫ60 mV, and all data are presented as mean Ϯ SEM where n indicates the number of cells recorded from. Time measurements were reciprocated before statistical analysis because the reciprocal of time is normally distributed. Data are shown untransformed. We determined statistical significance using either Student's t test or one-way repeatedmeasures ANOVA tests with Bonferroni correction as appropriate ‫,ء(‬ P Յ 0.05; ‫,ءء‬ P Յ 0.01; ‫,ءءء‬ P Յ 0.001).
Materials and Drugs. The solutions used were pipette solution [107 mM KCl͞1.2 mM MgCl 2 ͞1 mM CaCl 2 ͞10 mM EGTA͞5 mM Hepes͞2 mM MgATP͞0.3 mM Na 2 GTP (KOH to pH 7.2)͞Ϸ140 mM total K ϩ ) and bath solution (140 mM KCl͞2.6 mM CaCl 2 ͞1.2 mM MgCl 2 ͞5 mM Hepes, pH 7.4). Cell-culture materials were from GIBCO͞BRL and Invitrogen. All chemicals were from Sigma or Calbiochem. Drugs were made up as concentrated stock solutions and kept at Ϫ20°C.
Results
Using the whole-cell configuration of the patch-clamp technique we studied receptor-mediated G protein-gated Kir channel currents in a HEK293 stable cell line robustly expressing the Kir3.1ϩ3.2A channel complex (31) . To apply agonists we used a rapid and localized drug-perfusion system that enabled us to apply and remove agonist in under 0.25 s. We used five different dual-receptor and channel stable lines to investigate receptormediated Kir3. GGB cells. In this study we measured channel-deactivation rates () as currents return to baseline after the removal of agonist (indicated in Fig. 1 A Top) . The mean deactivation data for all five cell lines is shown in Fig. 1B ; strikingly there is a wide variation in deactivation rates ranging from Ϸ2 s in the HKIR3.1͞3.2͞M4 cell line to Ϸ30 s in the HKIR3.1͞3.2͞␣2A cells. Other clonal isolates of ␣ 2A in which binding was not characterized have faster deactivation rates (data not shown). We used the agonists 5Ј-N-ethylcarboxamidoadenosine (NECA) for A 1 , carbachol for M 4 , baclofen for GABA-B 1b/2 , quinpirole for D 2S , and noradrenaline for ␣ 2A . We also consistently observed in the HKIR3.1͞3.2͞A1 receptor line a transient reactivation in current after removal of agonist, which could often reach a similar magnitude to the initial potentiation. This never occurred in the HKIR3.1͞3.2͞M4, HKIR3.1͞3.2͞GGB, and HKIR3.1͞3.2͞D2 cells but occasionally occurred in the HKIR3.1͞3.2͞␣2 line (Ϸ30% of cells).
We first examined the effects of receptor occupancy on channel deactivation by varying the concentration of agonist used. Two agonist concentrations were chosen: a low concentration (approximately the EC 50 value) and a high, saturating concentration. These experiments were performed by using the HKIR3.1͞3.2͞GGB and HKIR3.2͞3.2͞A1 cell lines, and representative traces from the HKIR3.2͞3.2͞A1 cell lines with 30 nM and 1 M NECA are shown in Fig. 2A . As would be expected for a bimolecular reaction, agonist concentration did not influence channel deactivation after stimulation of either of these receptors (Fig. 2 B and C) . We next examined whether different agonists would affect channel deactivation, and for these experiments we used three different A 1 adenosine receptor agonists applied to HKIR3.1͞3.2͞A1 cells. We found that although NECA, adenosine, and N 6 -(R-phenylisopropyl)adenosine (R-PIA) (1 M) all produced agonist-induced currents of similar magnitudes (Fig. 3Ab) , the kinetics of the channel response were clearly different (Fig. 3Aa) . Although channel activation kinetics (lag ϩ time to peak) were not affected by the nature of the agonist (Fig. 3B ), a striking difference in deactivation kinetics among the three agonists was observed such that R-PIA caused the slowest deactivation, whereas adenosine induced the fastest deactivation (Fig. 3C) .
The use of engineered PTx-resistant G i/o ␣ subunits has made it possible to look exclusively at coupling between a number of G i/o -coupled receptors and the channel via different G i/o ␣ isoforms. We found previously that receptors exhibit different G proteincoupling profiles to activate the channel (27) . Recently we extended this approach to include a series of constructs of PTx-resistant G i/o ␣ subunits that are fused to the CFP. Such chimeric G proteins are membrane-targeted and functional (they can interact with G␤␥ dimers and inhibit adenylate cyclase activity); furthermore we established conditions under which these constructs are expressed at equivalent levels (28) . We compared deactivation rates via (Fig. 4B) .
We further investigated this phenomenon by looking at the role of RGS proteins in modulating the channel response to receptor stimulation. It has become apparent recently that the kinetics of Kir3.0 channel response can be influenced significantly by this family of proteins (17, 18) . Overexpression of RGS proteins leads to an increase in both the deactivation and, perhaps paradoxically, activation rates of Kir3.0 currents in heterologous expression systems (17, 18) . We examined whether one of the RGS proteins, RGS8, could differentially modulate the dynamics of current activation. We first examined this by overexpressing RGS8 in dual-receptor and channel stable lines and found marked differences in channel kinetics after RGS8 expression between different receptors. Although RGS8 had little effect on either activation or deactivation kinetics of A 1 -mediated currents (Fig. 5 A and B Right) , we found that overexpression of RGS8 solely increased deactivation rates after M 4 -receptor stimulation (Fig. 5 A and B Left) but increased both activation and deactivation rates of GABA Bmediated currents (Fig. 5 A and B Center) .
Finally, we investigated the role of RGS proteins by expressing a PTx-resistant G protein with an additional point mutation, G184S (designated RGSiG o ␣ A ) rendering it resistant to the actions of RGS proteins (29, 33) . When transiently transfected into the HKIR3.1͞ 3.2͞GGB line we found that this G␣ subunit was able to support GABA-B 1b͞2 -mediated channel activation with similar activation properties to G o ␣ A C351G but with very much slowed channeldeactivation kinetics (Fig. 6 Ai and Aii). In contrast, the A 1 receptor (ϩRGS8) of RGS8. In the HKIR3.1͞3.2͞M4 cell line, RGS8 affects only the deactivation kinetics but not the activation kinetics, whereas in the HKIR3.1͞3.2͞GGB cell line it significantly accelerates both activation and deactivation parameters; in the HKIR3.1͞3.2͞A1 cell line RGS8 has no effects at all. NS, not significant; ttp, time to peak. cell line showed no statistically different changes in kinetic parameters (Fig. 6B ) when constrained to signal via G i ␣ 1 C351G compared with the engineered RGS-insensitive, RGSiG i ␣ 1 (a PTxresistant G protein with point mutation G183S).
Discussion
After the initial cloning of the components constituting the atrial G protein-gated Kir channel (13-15), a major discrepancy remained. The deactivation rate after M 2 -muscarinic receptor activation was much slower with heterologous expression of Kir3.1 and Kir3.4 in X. laevis oocytes in comparison with that of the native atrial channel under analogous conditions. Subsequently it became apparent that this was due to the actions of a previously uncharacterized class of protein (the family of RGS proteins) (17, 34) . The preeminent hypothesis in the field is that channel-deactivation kinetics are determined by the G␣-GTP hydrolysis rates, and this process dictates how fast G␤␥ is sequestered by G␣-GDP. In general, the G␣-GTP hydrolysis rate is determined by the particular G protein, and this rate is modulated by RGS proteins and effectors with intrinsic GTPaseactivating activity such as phospholipase C␤ (21, 22) . Furthermore, it is now clear that Kir3.0 subunits are widely distributed in neuronal and neuroendocrine tissues and in principle can be regulated by a large variety of G i/o -coupled receptors (9-11, 16, 35-40) . The heterotetramer of Kir3.1 and Kir3.2A used in this study is likely to be equivalent to the channel found in many neuronal populations. Indeed the nature and numerical details of channel-activation and -deactivation kinetics we observe in our heterologous expression system are comparable to those observed with the native channel in hippocampal neurones. For example, baclofen-mediated responses in hippocampal neurones deactivate in Ϸ1 s after relatively prolonged agonist exposure, which is similar to our observations especially with RGS8 overexpression (12, 41) . With this much broader choice of heptahelical receptors, we question whether channel-deactivation kinetics are determined solely by the GTP hydrolysis rate of the G protein ␣ subunit.
In this study we investigated the factors that influence the deactivation of Kir3.1ϩ3.2A currents after agonist removal through a number of receptors and report data that are incompatible with the above hypothesis of channel-deactivation kinetics being solely determined by G␣-GTP hydrolysis. It is apparent that deactivation rates vary widely between the different GPCRs studied and are independent of receptor occupancy (i.e., agonist concentration). At a simplistic level it is possible to propose that either the channel, G protein, or receptor may be the major limiting factor in the deactivation phase of the kinetic response. Our initial observations of the widely varying deactivation rates between different receptors make it unlikely that G␤␥ binding and unbinding are the ratelimiting steps for channel activation and deactivation. However, it is paradoxical that binding assays with purified G␤␥ and channel domains can be performed with high nM͞low M affinities, and channel activation by G ␤␥ in inside-out patches occurs with a low nM EC 50 (9, (42) (43) (44) . Generally, nanomolar affinities are consistent with slow unbinding rates, which is discrepant with the observed deactivation rates. Speculatively, it is possible that association and dissociation of G protein ␣ subunits occurs with G␤␥ bound to channel, and residues important on G␤␥ for activation are masked by the ␣ subunit (45 (46) . These data are consistent with the idea that agonist unbinding is rate-limiting. It is noticeable that the ligands we use in these studies are largely synthetic agonists developed for enhanced affinity to their cognate receptor. However, other investigators have noticed significantly different deactivation rates between the ␣ 2A and ␣ 2C receptors with physiological agonists and postulated that agonist unbinding may be limiting with the latter (47) . In this regard our deactivation kinetics for noradrenaline at the ␣ 2A receptor, in the clonal isolate used here, are slower than those of others (33, 47) . Data (unpublished observations) indicate that it is possible to modulate the deactivation rate with RGS overexpression, and thus slow kinetics per se do not imply that agonist unbinding is rate-limiting. The endogenous peptide ligands for the opioid receptors are another potentially important group. However, the appreciation of such issues may have important consequences. In synaptic transmission for example, some agonist͞GPCR combinations may have more prolonged post-synaptic inhibitory effects. It also means that some receptor pathways can follow a rapidly changing stimulus, whereas others will time-integrate the signal to a new steady-state level. The fact that the channel essentially acts as a biosensor for membrane G␤␥ concentrations makes it likely that these observations can be extrapolated to other effectors activated by these receptor pathways.
It is clear that HEK293 cells contain endogenous RGS proteins; thus it is difficult to make categorical statements about the intrinsic hydrolysis rates of G protein ␣ isoforms in living cells. Our data do show significant differences for G i ␣ 2 and G o ␣ A with the M 4 receptor; however, this could reflect an intrinsic preference for certain G protein subunits by endogenous RGS proteins. Second, our data show that endogenous RGS proteins predominantly affect deactivation kinetics, whereas overexpression of RGS8 additionally accelerates the activation rate for GABA-B 1b/2 . In addition, overexpression of RGS8 seems to selectively accelerate activation kinetics for GABA-B 1b/2 but not the M 4 receptor. Generally the acceleration of the activation kinetics has been explained by physical or kinetic scaffolding, but this issue is still controversial (21, 48) . Our data show potential layers of selectivity and a role for level of RGS expression.
In summary, we propose that there are two processes that account for channel deactivation: agonist unbinding from the GPCR and GTP hydrolysis by the G protein ␣ subunit. With some combinations of agonist͞GPCR, the rate of agonist unbinding is slow and rate-limiting, and in another group deactivation is generally faster and is determined by the hydrolysis rate of the G protein ␣ subunit. The G protein isoform and interaction with RGS proteins play a significant role with this group of GPCRs.
